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Abstract 
Background: This position statement provides clinical recommendations for the assessment of pain, level of seda-
tion, iatrogenic withdrawal syndrome and delirium in critically ill infants and children. Admission to a neonatal or 
paediatric intensive care unit (NICU, PICU) exposes a child to a series of painful and stressful events. Accurate assess-
ment of the presence of pain and non-pain-related distress (adequacy of sedation, iatrogenic withdrawal syndrome 
and delirium) is essential to good clinical management and to monitoring the eﬀectiveness of interventions to relieve 
or prevent pain and distress in the individual patient.
Methods: A multidisciplinary group of experts was recruited from the members of the European Society of Paedi-
atric and Neonatal Intensive Care (ESPNIC). The group formulated clinical questions regarding assessment of pain 
and non-pain-related distress in critically ill and nonverbal children, and searched the PubMed/Medline, CINAHL and 
Embase databases for studies describing the psychometric properties of assessment instruments. Furthermore, level 
of evidence of selected studies was assigned and recommendations were formulated, and grade or recommenda-
tions were added on the basis of the level of evidence.
Results: An ESPNIC position statement was drafted which provides clinical recommendations on assessment of pain 
(n = 5), distress and/or level of sedation (n = 4), iatrogenic withdrawal syndrome (n = 3) and delirium (n = 3). These 
recommendations were based on the available evidence and consensus amongst the experts and other members of 
ESPNIC.
Conclusions: This multidisciplinary ESPNIC position statement guides professionals in the assessment and reassess-
ment of the eﬀectiveness of treatment interventions for pain, distress, inadequate sedation, withdrawal syndrome and 
delirium.
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Introduction
This position statement provides clinical recommenda-
tions for the assessment of pain, level of sedation, iat-
rogenic withdrawal syndrome (IWS) and delirium in 
critically ill infants and children. Admission to a neonatal 
or paediatric intensive care unit (NICU, PICU) exposes a 
child to a series of painful and stressful events. The eﬀects 
of these events are commonly resolved by the adminis-
tration of analgesics (e.g. morphine, fentanyl) and/or 
sedatives (e.g. benzodiazepines, α2-selective adrenergic 
agonists) [1]. However, sedation with benzodiazepines 
in neonates is advised against in view of the unfavour-
able patient outcomes [2]. A recent survey showed wide 
variety in both the dosages and choices of drugs admin-
istered to neonates [3]. While adequate analgesia and 
sedation help reduce the stress response and improve 
the clinical and psychological outcomes [4], inadequate 
analgesia and sedation will lead to pain, pain-induced 
agitation or undersedation and possibly to accidental 
extubation or removal of vascular access devices. Over-
use of analgesic and sedative agents, on the other hand, 
can lead to oversedation, prolonged ICU stay, longer 
ventilation times, drug tolerance and dependence. Fur-
thermore, IWS and delirium could be identified as side 
eﬀects of prolonged analgesia and sedation [5, 6]. Both 
are considered as concepts of non-pain-related distress 
in critically ill children. The current clinical guidelines on 
analgesic and sedative drugs use in adult and paediatric 
ICU populations [7, 8] are based on evidence of highly 
variable level.
Accurate and regular measurement of pain and non-
pain-related distress is essential, not only to establish 
their presence [9] but also to monitor the eﬀectiveness 
of interventions. The eﬀectiveness of pharmacological 
interventions should be monitored because this may be 
aﬀected by the specific pharmacokinetics and pharma-
codynamics in the individual critically ill child [10]. The 
gold standard of assessing patient comfort is self-report-
ing. Self-report is impossible, however, in preverbal and 
nonverbal children who are often sedated or when a tra-
cheal tube is in place. In these cases, healthcare profes-
sionals must resort to observing the child’s physiological 
and behavioural responses. Still, healthcare profession-
als’ observations and assessments of pain and non-pain-
related distress will depend on their ideas and beliefs on 
discomfort, pain, best drugs and treatment, and on their 
knowledge. On the other hand, as we know from adults 
[11], it may be diﬃcult to discriminate between pain, dis-
tress, IWS and delirium in critically ill children, because 
the behavioural cues will overlap in part (Fig. 1). There-
fore, standardized assessment tools have been proposed 
and validated so as to limit avoidable variability in assess-
ment [12]. In practice, a patient’s individual analgesia 
and sedation requirements will be assessed by diﬀerent 
nurses, with varying degrees of expertise, which may lead 
to inconsistent dosing of sedatives and analgesics [13]. 
Use of a standard tool may counteract this eﬀect and pro-
mote continuity of care [14].
This position paper specifically provides clinical rec-
ommendations for NICU and PICU healthcare clinicians 
on the assessment of pain, sedation, IWS and delirium in 
their patients.
Methods
A multidisciplinary group of expert clinicians and 
researchers in the fields of pain, sedation, withdrawal 
syndrome and delirium were recruited from the mem-
bership of the European Society of Paediatric and Neo-
natal Intensive Care (ESPNIC) to develop the position 
statement. The process of formulating the clinical rec-
ommendation comprised the following steps. First, 
questions were formulated regarding the clinical prac-
tice of assessment of pain-related and non-pain-related 
distress (e.g. adequacy of sedation, IWS and delirium) in 
critically ill and nonverbal children. Second, an exten-
sive search of the literature on assessment tools was per-
formed to find evidence for recommendations. For this 
reason, the PubMed/Medline, CINAHL and Embase 
databases were searched using the following MeSH and 
all fields search terms: (pain measurement, distress, 
sedation, iatrogenic withdrawal syndrome, delirium) 
AND (paediatric critical care OR neonatal intensive 
care) (see supplementary material for search strategy). 
The search scope was limited to studies in the English 
or French language published between August 2005 and 
August 2015, so as to provided the most up to date rel-
evant research, which included paediatric or neonatal 
critical care nonverbal inpatients, with the age limits set 
from birth to 18 years. Neonates were included, as they 
can be admitted to PICUs in some European settings. 
In the past few decades more than 40 neonatal pain 
assessment tools have been developed and validated. 
From two recent systematic reviews we derived the 
most recent evidence of the psychometric properties of 
neonatal pain (e.g. acute, prolonged pain) assessment 
instruments [15, 16]. On the basis on this, we described 
the psychometric properties of the most commonly 
used neonatal instruments. Additional search terms, 
such as pain questionnaires, pain scales, pain tools, 
pain instruments and search of authors known in the 
field served to verify completeness of the search results. 
Cross-referencing of key articles and recently published 
systematic reviews describing psychometric proper-
ties of assessment instruments [17, 18] served as a final 
check. Prior to full-text retrieval, studies describing 
the psychometric properties of instruments to assess 
physiological and behavioural cues of pain-related and/
or non-pain-related distress were selected on the basis 
of the title and abstract. Studies that did not report on 
psychometric properties of the tools and those that 
only reported on neonatal abstinence syndrome were 
excluded.
In the third phase, each of the articles selected was sub-
jected to an independent grade of evidence review by at 
least two of the authors and diﬀerences in grading were 
resolved through discussion. The level of the evidence 
was assigned a grade using the definitions provided in a 
supplementary table and based on reference test, specific 
research design and methodology [19]. Subsequently, 
recommendations for assessment of pain-related and 
non-pain-related distress in children were formulated 
and discussed by the group during a meeting. The rec-
ommendations were assigned according to the level of 
evidence. Lastly, to achieve consensus the draft position 
statement was reviewed by independent members of the 
ESPNIC Nursing Science section (Pain & Sedation study 
group) and the Pharmacology section; they graded the 
importance of the statements related to the topic area. 
This process did not lead to any fundamental changes. 
The final version was endorsed by the Executive Board of 
ESPNIC.
This position statement puts a focus on the assessment 
of (1) pain-related distress and (2) non-pain-related dis-
tress (level of sedation, withdrawal and delirium) in the 
NICU/PICU as a first essential step in the management 
of pain and distress in these vulnerable populations.
Results
Evidence from a total of 32 full-text articles describing 
the psychometric properties of assessment tools for pain-
related and non-pain-related distress in children was 
used to underpin the recommendations in this position 
statement (see supplementary material).
Assessment of pain-related distress
Pain assessment in hospitalised infants and children is 
notoriously diﬃcult because of the diﬀerent emotional 
and cognitive development stages of this patient group. 
Moreover, they are often ventilated and sedated, which 
complicates assessment of behaviours, and interpreting 
pain-related behaviours is often subjective, relying on the 
clinicians’ interpretation.
For intensive care settings, we can distinguish two 
relevant types of pain: (1) acute pain, including proce-
dural and postoperative pain (e.g. pain caused by heel-
stick, suctioning, venepuncture, thoracic drainage) and 
Fig. 1 Overlap of behavioural cues in pain, sedation, withdrawal syndrome and delirium
postoperative pain; and (2) prolonged pain (see Table  1 
for definitions). For clinical reasons it is important to 
explore the underlying pathogenesis and the context of 
pain (Fig. 2). However, diﬀerent types of pain, e.g. neuro-
genic pain, visceral pain and somatic pain, can not be dis-
tinguished with the use of observational assessment tools.
Children and neonates in the intensive care setting 
undergo numerous procedures which potentially cause 
pain, e.g. intravenous cannulation, chest drain insertion, 
intubation or discomfort, e.g. from invasive monitor-
ing lines. Nurses and physicians should be aware, how-
ever, that daily care (e.g. turning) can be painful as well, 
and that what is considered painful in older children and 
adults [20] should also be considered painful for children 
and neonates. Neonates are particularly at risk of pain 
exposure with a reported mean of 10.0–22.9 procedures 
per day [21, 22]. Prolonged pain is poorly understood, 
but is characterised by a lack of clear stimulus, a vari-
able duration and slow recovery [23]. Furthermore it is 
present after several days of hospitalisation and when no 
obvious cause for pain is present [24].
Recommendation
  • Identify potential sources of pain and take appropri-
ate actions (grade of recommendation = D).
The use of pain assessment instruments has been 
widely recommended as a means to provide consistency 
between clinicians, to provide an indication that pain/
discomfort is present and to assess the eﬀect of pharma-
cological or non-pharmacological interventions.
There is limited literature on pain assessment in the 
PICU; the available studies concern the validation of 
instruments such as the COMFORT scale [25, 26], the 
COMFORT-B scale1 [27–33], the FLACC scale [32, 34, 
35] and the Multidimensional Assessment Pain Scale 
(MAPS) [36, 37]. The COMFORT-B scale has also been 
validated for patients with burns [38]. In contrast, more 
than 40 pain assessment instruments for neonates have 
been developed in the last few decades, but not all meet 
the minimum psychometric requirements for application 
in clinical practice [16]. The well-established, validated 
COMFORT-B scale and the FLACC scale (for infants and 
children) [39] and the promising PIPP-R (for neonates) 
[40, 41] are recommended (see Tables 2, 3 and supple-
mentary material for their psychometric properties).
1 The COMFORT scale was originally developed for assessing the level of 
distress in ventilated children. In combination with the use of the NRS pain 
the COMFORT-B scale is suitable to determine the need for analgesia or 
sedation.
Table 1 Definitions of pain, distress, withdrawal syndrome and delirium
IASP international association for the study of pain
Pain
“An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Note: The 
inability to communicate verbally does not negate the possibility that an individual is experiencing pain and is in need of appropriate pain-relieving 
treatment” (IASP 2014)
Acute pain “Acute pain should be viewed as the initiation phase of an extensive, persistent nociceptive and behavioural cascade triggered by tissue 
injury. This cascade has the potential to span orders of magnitude of space and time, but generally subsides within weeks” [89]
Postoperative pain Acute pain experienced post-surgery
Prolonged pain The terms prolonged and recurrent are used interchangeably in the literature. Prolonged or persistent pain is primarily caused by disease 
e.g. peritonitis. Prolonged pain diﬀers from chronic pain in that there is a clear stimulus caused by disease (e.g. peritonitis) or therapy (e.g. mechani-
cal ventilation, insertion of tubes or drains), with a clear definable beginning and an expected endpoint. But less than 3 months and full recovery of 
tissue damage can be expected, which is not the case in chronic pain [23]
Non-pain-related distress
Distress is an organism’s response to aversive internal and external stimuli and may include discomfort, anxiety and fear [25]
Optimal sedation A state in which the patient is somnolent, responsive to the environment but untroubled by it, and with no excessive movements [13]
Iatrogenic withdrawal syndrome
A clinical syndrome that manifests after stopping or reversing a drug after prolonged exposure to that drug [3, 4]
Tolerance A decrease in a drug’s eﬀect or the need to increase the dose to achieve the same eﬀect [3, 4]
Physiological dependence The requirement for continued administration of a sedative or analgesic to prevent signs of withdrawal syndrome
Delirium
A neurocognitive disorder due to a somatic illness or its treatment [61]
DSM-5 criteria:
A. Disturbance in attention (i.e. reduced ability to direct, focus, sustain and shift attention) and awareness (reduced orientation to the environment)
B. The disturbance develops over a short period of time (usually hours to a few days), represents an acute change from baseline attention and aware-
ness, and tends to fluctuate in severity during the course of a day
C. An additional disturbance in cognition (e.g. memory deficit, disorientation, language, visuospatial ability or perception)
D. The disturbances in Criteria A and C are not better explained by a pre-existing, established or evolving neurocognitive disorder and do not occur in 
the context of a severely reduced level of arousal such as coma
E. There is evidence from the history, physical examination or laboratory findings that the disturbance is a direct physiological consequence of another 
medical condition, substance intoxication or withdrawal (i.e. due to a drug of abuse or to a medication), or exposure to a toxin, or is due to multiple 
etiologies
Recommendation
  • Use an age-appropriate tool to assess acute and pro-
longed pain i.e. the PIPP(-revised) in neonates and 
the COMFORT behaviour scale, FLACC or MAPS in 
critically ill children (grade of recommendation = A).
The vital signs heart rate and mean arterial pres-
sure have been moderately correlated with behaviour 
items [28, 42]. In children, these vital signs are prob-
ably less reliable indicators of pain than behavioural 
indicators. In heavily sedated or muscle-relaxed 
children, however, increases in heart rate and mean 
arterial pressure may indicate that the body is under 
some stress—in the absence of behavioural signs pain 
must be one of the considerations in this scenario, the 
more so as there is no other method to assess these 
children.
It must be remembered that in the case of pain or dis-
comfort in the nonverbal child, reflected by a high score, 
the practitioner should acknowledge possibly contribut-
ing environmental factors (temperature, noise) or other 
factors such as the need for a change of position, infant 
teething or the need for nappy care. It is assumed that the 
nurse will check and modify these environmental factors 
first before making a treatment plan and reassess once an 
intervention has taken place.
Studies have shown that parents themselves wish to be 
more involved in the process of assessing pain in their 
Fig. 2 Interpretation of pain and non-pain-related distress in critically ill children, based on van Dijk et al. 2012 [16]
child and urge for more consistent pain assessment and 
management practices by staﬀ. Parents’ knowledge of 
their own child and how they may display pain or distress 
may enhance a clinician’s assessment and management 
practices. Further research is needed with regard to pain 
assessment involving families.
Recommendation
  • Parent and family assessment of pain should be con-
sidered in pain assessment (grade of recommenda-
tion = D).
There are no clear-cut recommendations in the litera-
ture on the frequency of pain assessment; this position 
statement merely provides the clinician with a consensus 
on the frequency. Furthermore, the frequency of assess-
ment will depend on the goal of therapeutic treatment 
(e.g. weaning of ventilation, transfer to paediatric ward).
Recommendation
  • Pain assessment should take place routinely, depend-
ing on therapeutic goals, but at greater frequency 
(1–2 h) if the patient is receiving any analgesic infu-
sion (grade of recommendation = D).
Audits of pain assessment should take place regularly 
(e.g. every 12 months) to evaluate the quality of patient 
care and patient outcomes [43].
Recommendation
  • Pain assessment audits should take place regularly 
(grade of recommendation = C).
Non-pain-related distress
Sedation assessment
Patients admitted to an intensive care unit are likely to 
develop physical and psychological distress. Non-pain-
related distress in ventilated children is treated with seda-
tives. Optimal sedation has been described as a state in 
which the patient is somnolent, responsive to the environ-
ment but untroubled by it and without excessive move-
ments [13] (Table 1). In practice this means that a child 
is conscious, breathes in synergy with the ventilator and 
is tolerant or compliant to other therapeutic procedures. 
Still it can be challenging to reach this level of sedation. 
A recent systematic review revealed that across all stud-
ies of paediatric patients (n = 25), patients were optimally 
sedated in 58 %, undersedated in 10 % and oversedated in 
32 % of the observations [44]. Optimal level of sedation 
varies for each patient and careful consideration should 
be given to the underlying diagnosis and severity of ill-
ness [1, 13]. Oversedation may lead to longer duration of 
Table 2 Panel of behavioural instruments specific to pae-
diatric critical care
SBS State Behavioural Scale
a Crying only in spontaneous breathing patients
COMFORT behavior scale
Categories Score
  Alertness 1–5
  Calmness/agitation 1–5
  Respiratory response or cryinga 1–5
  Physical movement 1–5
  Muscle tone 1–5
  Facial tension 1–5
Total score 6–30
Withdrawal Assessment Tool version 1 (WAT-1)
  Information from patient record
    Loose/watery stools No = 0, yes = 1
    Vomiting/retching/gagging No = 0, yes = 1
    Temperature > 37.8 °C No = 0, yes = 1
  2 min pre-stimulus observation
    State SBS ≤ 0 = 0, SBS ≥ 1 = 1
    Tremor No = 0, moderate/severe = 1
    Any sweating No = 0, yes = 1
    Uncoordinated/repetitive movement No = 0, moderate/severe = 1
    Yawning of sneezing No = 0, yes = 1
  1 min stimulus observation
    Startle to touch No = 0, moderate/severe = 1
    Muscle tone Normal = 0, increased = 1
  Post-stimulus recovery
    Time to gain calm state (SBS ≤ 0) 0–2
Total score 0–12
Sophia Observation withdrawal Symptoms-scale (SOS)
Items Score
  Autonomic dysfunction
    Tachycardia No = 0, yes = 1 (for all items)
    Tachypnoea
    Fever (≥38.5 °C)
    Sweating
  CNS irritability
    Agitation
    Anxiety
    Tremors
    Increased muscle tension
    Inconsolable crying
    Grimacing
    Sleeplessness
    Motor disturbance
    Hallucinations
  Gastrointestinal dysfunction
    Vomiting
    Diarrhoea
Total score 0–15
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mechanical ventilation and increased healthcare costs. On 
the other hand, undersedation can lead to increased dis-
tress, self- or accidental extubation, accidental displace-
ments of catheters, tubes and vascular access. In clinical 
practice it can be challenging to reach the optimal level of 
sedation in infants and children. The majority of children 
in the PICU are below 4 years of age and, in view of their 
development, not yet able to understand or make sense 
of their situation, and they will more easily become anx-
ious and scared. For this reason they often need greater 
amounts of sedatives to ensure lines and tubes remain 
in situ.
The sedation goal may vary considerably from patient 
to patient and depends on severity of illness, type of dis-
ease and treatment as well as environmental factors, such 
as noise. When a child shows signs of agitation and fight-
ing against the ventilator, the child should be sedated 
after confirmation that the ventilator settings are well 
adjusted to the child’s respiratory needs.
Recommendation
  • Search for potential causes of non-pain-related dis-
tress/discomfort to take appropriate actions (grade of 
recommendation = D).
Although clinical judgement of trained ICU profession-
als is important, the use of a sedation assessment tool is 
needed to determine the eﬃcacy of sedatives and related 
interventions, to facilitate inter-institutional comparisons 
and to facilitate targeted sedation. Several behavioural 
sedation scoring scales (e.g. COMFORT scale [25, 45], 
COMFORT behaviour scale [14, 42], State Behaviour 
Scale [46]) have been described and validated for children 
(Tables 2, 4, supplementary material). Also, these tools are 
the most commonly used instruments in daily practice [47]. 
No single instrument has been shown to be superior for 
use in this population, and it is advisable to select a scale 
that has been validated for this patient population. The 
frequency of assessment reported in the included studies 
(n = 25) varied considerably i.e. from once daily to hourly 
[44]. Although the frequency of assessment will depend on 
whether symptoms have been controlled or not and on the 
goal of therapeutic treatment (e.g. weaning of ventilation), 
we recommend regular assessment at least once per shift 
and accurate documentation of the sedation score.
Recommendation
  • Use standardized sedation assessment tools with 
proven validity, reliability and clinical utility; the 
COMFORT behaviour scale (grade of recommenda-
tion = A).
  • Together with the vital signs, the level of sedation 
must be assessed and documented every 4–8 h or as 
indicated by the sedation score or the child’s clinical 
condition (grade of recommendation = D).
Iatrogenic withdrawal syndrome assessment in infants 
and children
Prolonged administration of opioids and/or benzodiaz-
epines in infants and children may induce drug tolerance 
Table 4 Sedation: summary of recommended assessment tools for critically ill children
See supplementary material for detailed data regarding psychometric properties
COMFORT scale  
[25, 45, 98]
COMFORT behaviour scale  
[14, 31, 32, 42, 99]
State Behavioural Scale  
(SBS) [46]
Age range 0–16 years 0–16 years 6 weeks–6 years
Variables assessed Distress
Heart rate
Mean arterial pressure
Alertness
Calmness
Respiratory response
Movement
Muscle tone
Facial expression
Distress
Alertness
Calmness/agitation
Respiratory response or crying
Physical movement
Muscle tone
Facial tension
Respiratory drive
Coughing
Best response to stimuli
Attentiveness to care provider
Tolerance to care
Consolability
Movement after consoled
Score range
(cut-oﬀ point)
8–40
<17 oversedation
17–26 optimal sedation
>26 undersedation
6–30
<11 oversedation
11–22 adequate sedation
>22 undersedation
6-point scale; state behaviour on a scale of 
−3 to +2
0 = awake and calm
Reliability data + + +
Forms of validity  
established
Face, construct and  
concurrent
Face, construct and concurrent,  
responsiveness
Face, construct
Clinical utility Feasibility and utility established at bedside Feasibility and utility established at bedside
Grade A A B
and physiological dependency. Abrupt discontinuation or 
(too rapid) weaning of these drugs in physically depend-
ent infants and children may result in IWS (Table 1) [6, 
48].
Tolerance and withdrawal symptoms may occur after 5 
or more days of continuous infusion of opioids or ben-
zodiazepines in infants as well as children. The onset of 
withdrawal can occur after 1 up to 48 h after tapering oﬀ 
or discontinuation [6, 48]. An estimated 10–34 % of all 
PICU patients are at risk of IWS [49, 50]. Fentanyl and 
morphine are the most frequently used analgesic drugs in 
the NICU and PICU that underlie opiate IWS, with prev-
alence rates of 9–57 % [51, 52]. The reported prevalence 
rates of IWS in PICU patients who had received benzodi-
azepines and/or opioids for 5 or more days range from 35 
to 57 % [53, 54].
Recommendation
  • The potential risk of opioid and/or benzodiazepine 
iatrogenic withdrawal syndrome should be consid-
ered after 5  days of continuous administration of 
these drugs (grade of recommendation = C).
Diagnosing withdrawal symptoms in NICU and 
PICU patients is complicated by the fact that these 
symptoms may overlap with clinical signs of pain 
or distress, respiratory distress, delirium and noise-
induced stress [6, 55, 56]. These other factors must 
be excluded before the diagnosis can be confirmed. 
Regarding the fact that IWS may occur after 5  days, 
we recommend to continue assessment of withdrawal 
symptoms after the child has been discharged from the 
PICU.
Two instruments for assessing IWS in children have 
been suﬃciently validated, namely the Withdrawal 
Assessment Tool version 1 (WAT-1) [57, 58] and the 
Sophia Observation withdrawal Symptoms-scale (SOS) 
[59, 60]. The WAT-1 is an 11-item scale and scores of 
3 or higher (on a scale of 0–12) indicate that the child 
is suspected of experiencing withdrawal. The SOS 
consists of 15 items and is based on the underlying 
empirical structure of co-occurrences of withdrawal 
symptoms that experts considered relevant. A SOS 
score of 4 or higher reflects a high probability of with-
drawal. Table  5 and supplementary material provide 
details on symptoms and the psychometric properties 
of these instruments, which are used in practice and in 
research.
Recommendation
  • Use standardized IWS assessment instruments 
with proven clinical utility, validity and reliability in 
infants and children; WAT-1 or the SOS (grade of 
recommendation = A).
Delirium
Delirium is a neurocognitive disorder due to a somatic 
illness or its treatment. According to DSM-5 the core 
diagnostic criteria for delirium are (Table  1) (a) a dis-
turbance of attention or awareness; (b) this disturbance 
is accompanied by changes in cognition that cannot be 
better accounted for by another pre-existing neurocogni-
tive disorder (e.g. mental retardation, dementia); (c) the 
condition develops within hours or days, and often fluc-
tuates during the day, typically worsening in the even-
ing (‘sundowning’) and (d) there are indications from the 
patient’s history, examination or laboratory results that 
the disturbance is probably the result of a medical condi-
tion or its treatment [61]. The pathogenesis of delirium 
is largely unknown. The suﬀerers may be hyperactive, 
hypoactive or show signs of both states. Typical for the 
hypoactive delirium are slowed or sparse speech, hypo-
active or slowed motor activity as well as lethargy, also 
described as reduced awareness or apathy. Adults and 
children largely show the same symptoms although hallu-
cinations and hypoactive delirium are hard to observe in 
the very young children [62]. However, delirium has been 
described in infants below 1  year of age [63]. Delirium 
has not been described in neonates to date. Increasing 
evidence suggests there is a positive association between 
illness severity and paediatric delirium [64]. Many risk 
factors for delirium have been identified. These can be 
classified as patient-related, iatrogenic and environmen-
tal. Patient factors (e.g. infections, metabolic disorders, 
withdrawal from medications, restraints and sleep dis-
turbance) and environmental factors may contribute to 
developing delirium [56].
The reported prevalence of paediatric delirium (PD) 
in PICU patients is 4–29 % [56, 65, 66]. Colville et  al. 
found that 3 months after discharge one-third of PICU 
patients reported memories of psychotic features, includ-
ing delusions and disturbing hallucinations, suggestive 
of delirium during PICU admission [67]. Adult delirium 
has been associated with higher mortality and morbidity 
and longer length of hospital stay [68]. PD, too, is asso-
ciated with longer length of stay [69] and—as we sus-
pect—increased morbidity. Thus, early recognition of this 
serious neuropsychiatric disorder is essential, and PICU 
nurses could facilitate this task.
Recommendation
  • Search for potential sources of paediatric delirium 
and to take appropriate actions (grade of recommen-
dation = D).
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Delirium assessment
According to the literature, PD is underdiagnosed espe-
cially in young critically ill children [56]. A likely reason 
is that nurses and ICU physicians do not specifically 
focus on the symptoms of PD; and moreover, it is diﬃcult 
to assess the symptoms in preverbal patients. Looking 
at behaviours has been suggested as an alternative [56, 
63]. Taking into account the child’s developmental stages 
makes it possible to reliably and accurately interpret 
alterations in behaviour, communication and emotion in 
the critically ill child of any age [70]. A number of delir-
ium symptoms overlap with those observed in other con-
ditions, such as pain, distress and withdrawal syndrome 
[6]. Thus it would seem essential to use a reliable, vali-
dated and clinically useful bedside tool to screen delirium 
and guide treatment. This is an area of development but 
assessment instruments are already available. These are 
(1) the paediatric Confusion Assessment Method for ICU 
(pCAM-ICU) for children of 5 years or older [66]; (2) the 
Cornell Assessment Paediatric Delirium tool (CAP-D) 
for children of 0 up to 18 years of age [65, 71] and (3) the 
Sophia Observation withdrawal Symptoms-Paediatric 
Delirium scale [72, 73] (Table  5; supplementary mate-
rial). In the lack of evidence, we recommend assessment 
of delirium at least once per shift or as indicated by the 
clinical condition of the child.
Recommendation
  • Use CAP-D as an instrument to assess paediatric 
delirium (grade of recommendation = A).
  • Together with the vital signs, delirium must be 
assessed and documented every 8–12 h (at least once 
per shift), 24–48 h after admission or as indicated by 
the delirium score of clinical condition of the child 
(grade of recommendation = D).
Pain and non-pain-related distress management protocols 
in relation to assessment
Eﬀective pain and sedation management depends on the 
eﬀectiveness of analgesics and sedatives as well as the 
use of assessment instruments to measure the eﬀects 
and target of the administered drugs. A number of ran-
domised controlled trials (RCTs) have provided evidence 
for the use of individual drugs such as morphine, mida-
zolam, paracetamol, clonidine and dexmedetomidine 
[74–77]. The combined use of drugs in infants has also 
been evaluated, like fentanyl versus remifentanil com-
bined with midazolam [78] or remifentanil versus mida-
zolam [79]. The use of fentanyl or morphine is common 
practice around the world for postoperative analgesia in 
term newborns, infants and children, with recommended 
continuous infusions and dosages of 1–5 mcg/kg/h (fen-
tanyl) and 10–40 mcg/kg/h (morphine), respectively [8]. 
Opioids and/or benzodiazepines are often given during 
artificial ventilation. The use of morphine as the drug of 
first choice for postoperative analgesia has been debated 
given the equipotency of intravenous paracetamol as the 
drug of first choice. With regards to sedation, Curley et al. 
failed to show beneficial eﬀects of protocolized seda-
tion versus usual care on length of artificial ventilation 
in a multicentre cluster randomised study of 31 PICUs 
in the USA [80]. Still, daily interruption of sedatives sig-
nificantly improved short- and long-term outcomes in 
adults. All evidence indicates that the use of sedatives 
should be reduced. In children, daily interruption of seda-
tion seems feasible and safe [81, 82]. However, the eﬀec-
tiveness needs to be demonstrated in large trials [83]. 
Following the evaluation of the level of evidence of anal-
gesic and sedative drugs by Playfor [8], increased atten-
tion is being paid to optimal dosing of many of the drugs 
used routinely in the PICUs around the world. Studies 
have demonstrated that reassessment after an interven-
tion is often neglected, although it is crucial in evaluat-
ing whether an intervention is eﬀective or not [84, 85]. In 
summary, the overall aim of assessment of pain and non-
pain-related distress in relation to treatment is to find the 
most appropriate dose for the individual patient to elimi-
nate or reduce pain and discomfort to an acceptable level 
without side eﬀects of therapy. Therefore, we recommend 
that the eﬀect of a drug (e.g. increasing or decreasing of 
a pump, bolus) is re-evaluated depending on the drug’s 
half-life. One value outside the normal range of the score 
should not immediately result into a change in drug dos-
ages. Strategies to reduce the incidence of IWS should 
begin by making eﬀorts to reduce doses of benzodiaz-
epines and/or opioids, and thereby preventing overseda-
tion [44, 86].
Recommendation
  • The eﬀect (e.g. increasing or decreasing of a pump, 
bolus) of a drug should be re-evaluated depending on 
the drug’s half-life (grade of recommendation = D).
A weaning strategy for gradual decreasing of opioid 
and/or benzodiazepine dosages is essential to prevent 
IWS. Strategy options include slowly tapering oﬀ the 
intravenous infusion rate or using an alternative route, 
like the enteral or subcutaneous route. However, the evi-
dence of diﬀerent strategies is scarce. At each step in the 
weaning process, possible withdrawal symptoms should 
be carefully monitored with the help of the WAT-1 or 
SOS.
Recommendation
  • Reassess for symptoms of withdrawal after treatment 
interventions (grade of recommendation = D).
Delirium in PICU patients has been treated with halo-
peridol and risperidone and both drugs demonstrated 
beneficial eﬀects without significant side eﬀects [56]. 
There remains a need for well-designed, randomised, 
placebo-controlled trials assessing the eﬃcacy and 
safety of delirium drug therapy. Clinical pharmacologi-
cal principles should go hand in hand with the daily use 
of validated assessment instruments with good psycho-
metric properties. In this way optimal dosing and evalu-
ation of specific behaviours of the individual critically ill 
patient will result in optimal synergy between care and 
cure.
Recommendation
  • Validated assessment tools for pain, sedation, with-
drawal syndrome and delirium should be integrated 
in pain and non-pain-related treatment protocols 
(grade of recommendation = C).
Discussion and conclusion
Providing comfort and minimizing anxiety, fear and dis-
tress in critically ill infants and children are an impor-
tant part of the daily activities of intensive care nurses. 
These patients, who are unable to communicate their 
pain, discomfort, anxiety and fear, are at great risk of 
inadequate analgesia, sedation or delayed recognition 
of withdrawal syndrome and/or delirium. Just like all 
infants and children, this special population deserves 
consistent, on-going assessment and reassessment of 
interventions to confirm the best possible treatment 
for pain, distress, inadequate sedation, withdrawal syn-
drome and delirium. This position paper oﬀers recom-
mendations to this aim. To achieve the best possible 
outcome, interdisciplinary collaboration of nurses, 
physicians and hospital pharmacists/clinical phar-
macologists is therefore warranted. Distress can be 
reduced by creating an optimal environment with lit-
tle noise (<45 dB), favourable conditions for day-night 
(sleep) rhythm in combination with daylight, and fam-
ily presence [87]. However, more research is needed 
to establish the eﬀectiveness of non-pharmacological 
interventions in critically ill children. Furthermore, the 
nursing role includes providing information to parents, 
asking them about the nature and intensity of pain and 
distress of their infant or child and consequently lis-
tening to parents. This requires a particular awareness, 
knowledge of and insight into these phenomena. It may 
be diﬃcult to discriminate between pain, distress, IWS 
and delirium in critically ill children, because the behav-
ioural cues will overlap in part (Fig. 1). Pain frequently 
results in distress, but distress may have other causes 
than pain. Despite their close association, distinguishing 
between these concepts is clinically important as they 
are treated diﬀerently. A behavioural tool that is able to 
discriminate pain, sedation, IWS and delirium in all cir-
cumstances is not available. It could be challenging for 
clinicians to deal with all these diﬀerent instruments. 
The decision to apply a particular instrument should 
always be driven by interpreting factors related to the 
context of the patient (e.g. use of sedatives, postopera-
tive, prolonged administration of sedatives/opioids as 
a risk for IWS), environment and response to therapies 
(see Fig.  2). Combining this with the diﬀerent scores 
then allows one to decide on the necessary action.
As the evidence for several recommendations is poor 
(e.g. grade D recommendations) further research is 
needed to strengthen these recommendations. Clini-
cians are recommended to select a validated and reli-
able assessment instrument and could be guided in the 
choice by the grade of recommendation. Furthermore, 
other factors should be considered like the ease of use, 
complexity of the tool and the time it takes to complete 
the assessment. All staﬀ working on the NICU or PICU 
(physicians, nurses and nursing support staﬀ ) should 
be trained in the application of these instruments. Fur-
thermore, assessment outcomes should be integrated 
in treatment decision trees with recommended dos-
ages based on RCTs in paediatric patients. In addition 
to pain as the fifth vital sign, it may be time to also 
endorse non-pain-related distress in critically ill infants 
and children as the composite sixth vital sign [88].
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